Reckitt Benckiser Group plc, the global consumer goods company, is making waves in the market with its plans to sell its £6 billion homecare assets, a bold step to streamline its business and focus on high-growth areas. The company has entered into early discussions with potential buyers, including both financial investors and consumer companies, to […]
Reckitt Benckiser Group has agreed to divest 92% stake in Infant Formula and Child Nutrition business in China (IFCN China) to Primavera Capital Group, a Chinese investment firm, for about $1.3 billion in cash. The deal values 100% of the Chinese infant formula business at $2.2 billion. Reckitt Benckiser will retain a stake of 8% […]
Reckitt Benckiser Group (RB) has agreed to acquire the Biofreeze topical pain relief brand from Madison Dearborn Partners subsidiary Performance Health for an undisclosed price. Biofreeze is said to be among the popular brands for topical pain relief brand and had generated double-digit sales growth. Francis X. Dirksmeier – CEO of Performance Health said: “The […]
Pfizer’s $20 Billion Sale Stalls: In a significant turn of events in the pharmaceutical industry, both Reckitt Benckiser and GlaxoSmithKline (GSK) have decided to withdraw from acquisition talks with Pfizer regarding its consumer healthcare business. This decision marks a setback for Pfizer’s plans to offload this segment, valued at approximately $20 billion. Overview of Pfizer’s […]